We are live on
!
Find out more
PAIA
Park Avenue Institutional Advisers Portfolio holdings
AUM
$199M
This Fund
S&P 500
This Quarter
Est. Return
+36.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.01M
AUM Growth
-$98.5M
(-99%)
Cap. Flow
-$98.7M
Cap. Flow
% of AUM
-9,811.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
3
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$335K |
| 2 |
TTAN
ServiceTitan Inc
TTAN
|
+$269K |
| 3 |
Braze
BRZE
|
+$263K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JABS
Janus Henderson Asset-Backed Securities ETF
JABS
|
+$99.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.5% |
| 2 | Healthcare | 40.5% |
Similar funds
SPI
PFA
FWM
CASB
BMA
PMIA
SCM
PS
Park Avenue Institutional Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, Park Avenue Institutional Advisers held 4 positions worth $1.01M, down 99% from $99.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Park Avenue Institutional Advisers withdrew a net $98.7M in Q4 2025, closing 1 position. Its most notable exit was Janus Henderson Asset-Backed Securities ETF, an estimated $99.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 59% of assets, followed by Healthcare.
Against the trend, Park Avenue Institutional Advisers opened a new position in Revolution Medicines worth $407K.
- Park Avenue Institutional Advisers's largest Q4 2025 buy was Revolution Medicines: 5,115 shares worth $407K.
- Park Avenue Institutional Advisers fully exited Janus Henderson Asset-Backed Securities ETF in Q4 2025, selling an estimated $99.6M.
- Park Avenue Institutional Advisers's ten largest holdings make up 100% of its $1.01M portfolio in Q4 2025.
- Park Avenue Institutional Advisers opened 3 new positions and closed 1 in Q4 2025.
- Park Avenue Institutional Advisers's portfolio value fell 99% quarter-over-quarter to $1.01M.
Based on Park Avenue Institutional Advisers's 13F filing for Q4 2025, filed 10 Feb 2026.